After a train derailed in Harlem, Cuomo is throwing money, entrepreneurs, and big promises at the MTA's numerous problems.
NYS Entity Status
NYS Filing Date
FEBRUARY 24, 2014
NYS DOS ID#
DANIEL AYZENBERG CPA, ESQ
287 SPRING STREET
NEW YORK, NEW YORK, 10013
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - BIG APPLE LIVING, LLC
AROUND THE WEB
- New York Gov. Andrew Cuomo Declares A State Of Emergency For The Big Apple’s Subway System
By emmieodea - Thursday Jun 29, 2017
- Fit City: Taking Night-Life Cue, Gyms Lower the Lights
By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017
Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.
- Trump slams NY Times story about Pence 2020 bid as ‘totally inept’
By Yaron Steinbuch - Monday Aug 7, 2017
President Trump slammed The New York Times early Monday for reporting that several Republicans — including Vice President Mike Pence — are angling for a presidential run in 2020. “The failing @nytimes, which has made every wrong prediction about me including my big election win (apologized), is totally inept!”
- Living the Urban Life Upstate
By KIM VELSEY - Friday Jun 16, 2017
A New York couple who prefer to rent in the thick of things, even in a Hudson Valley town.
- Man convinced living room painting is $300M Michelangelo masterpiece
By Associated Press - Thursday Jul 20, 2017
TONAWANDA, N.Y. — Martin Kober is convinced the painting of a dying Jesus that hung above the mantel in his upstate New York childhood home is the work of Michelangelo. Getting experts to agree remains the $300 million hurdle. That’s the potential value of the 19-by-25-inch work that Kober’s family affectionately calls the “the Mike,”...
- IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
By Ben Fidler - Thursday Aug 3, 2017
Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]